PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE 250

286.00p
   
  • Change Today:
      8.00p
  • 52 Week High: 292.00
  • 52 Week Low: 160.00
  • Currency: UK Pounds
  • Shares Issued: 282.61m
  • Volume: 80,625
  • Market Cap: £808.28m

PureTech's Karuna Therapeutics closes $102.6m IPO

By Josh White

Date: Wednesday 03 Jul 2019

LONDON (ShareCast) - (Sharecast News) - Biopharmaceutical company PureTech Health announced on Wednesday that its affiliate Karuna Therapeutics has closed of its initial public offering of 6,414,842 shares of common stock at a public offering price of $16.00 per share.
The London-listed firm said that included the full exercise of the underwriters' option to purchase 836,718 additional shares.

It said the gross proceeds from the offering were approximately $102.6m, before deducting underwriting discounts and commissions and estimated offering expenses payable by Karuna.

The shares started trading on the Nasdaq Global Market under the ticker symbol 'KRTX' on 28 June.

"Karuna is an innovative clinical-stage biopharmaceutical company primarily focussed on developing novel therapies to address disabling neuropsychiatric conditions characterised by significant unmet medical need," the company's statement read.

"Karuna is currently conducting a phase 2 clinical trial of its lead product candidate, Karuna-Xanomeline-Trospium (KarXT), for the treatment of acute psychosis in patients with schizophrenia.

"Karuna also plans to initiate clinical trials of KarXT to evaluate its potential therapeutic benefit in other central nervous system disorders, including psychosis in Alzheimer's disease, as well as pain."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

PRTC Market Data

Currency UK Pounds
Share Price 286.00p
Change Today 8.00p
% Change 2.88 %
52 Week High 292.00
52 Week Low 160.00
Volume 80,625
Shares Issued 282.61m
Market Cap £808.28m

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.31% below the market average38.31% below the market average38.31% below the market average38.31% below the market average38.31% below the market average
17.24% below the sector average17.24% below the sector average17.24% below the sector average17.24% below the sector average17.24% below the sector average
Price Trend
98.10% above the market average98.10% above the market average98.10% above the market average98.10% above the market average98.10% above the market average
93.22% above the sector average93.22% above the sector average93.22% above the sector average93.22% above the sector average93.22% above the sector average
Income Not Available
Growth
68.51% above the market average68.51% above the market average68.51% above the market average68.51% above the market average68.51% above the market average
89.19% above the sector average89.19% above the sector average89.19% above the sector average89.19% above the sector average89.19% above the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

PRTC Dividends

No dividends found

Trades for 13-Sep-2019

Time Volume / Share Price
16:35 27,236 @ 286.00p
16:29 201 @ 290.00p
16:29 36 @ 290.00p
16:29 294 @ 290.00p
16:29 984 @ 289.00p

PRTC Key Personnel

CEO Daphne Zohar
CFO Santosh Shanbhag

Top of Page